1. Home
  2. CRMT vs KTTA Comparison

CRMT vs KTTA Comparison

Compare CRMT & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$3.05

Market Cap

19.7M

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

N/A

Current Price

$0.50

Market Cap

18.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRMT
KTTA
Founded
1981
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
18.1M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
CRMT
KTTA
Price
$3.05
$0.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$29.50
$3.00
AVG Volume (30 Days)
231.1K
290.8K
Earning Date
06-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.07
EPS
N/A
N/A
Revenue
$1,281,502,000.00
$486,559.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3130.37
52 Week Low
$1.38
$0.28
52 Week High
$47.93
$2.06

Technical Indicators

Market Signals
Indicator
CRMT
KTTA
Relative Strength Index (RSI) 41.70 53.85
Support Level $1.38 $0.48
Resistance Level $3.67 $0.52
Average True Range (ATR) 0.28 0.04
MACD 0.04 0.01
Stochastic Oscillator 14.25 71.95

Price Performance

Historical Comparison
CRMT
KTTA

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: